BX Swiss TOP 30 CHF
1.276,51
PKT
+5,72
PKT
+0,45
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.08.15 | Givaudan Neutral | UBS AG | |
| 12.08.15 | Zurich Insurance Hold | HSBC | |
| 12.08.15 | UBS Halten | Bankhaus Lampe KG | |
| 12.08.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 12.08.15 | UBS buy | Goldman Sachs Group Inc. | |
| 12.08.15 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 11.08.15 | UBS Neutral | Credit Suisse Group | |
| 11.08.15 | Zurich Insurance overweight | Barclays Capital | |
| 11.08.15 | Swiss Re overweight | Morgan Stanley | |
| 10.08.15 | Zurich Insurance Verkaufen | DZ-Bank AG | |
| 10.08.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.08.15 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.08.15 | Novartis buy | Jefferies & Company Inc. | |
| 07.08.15 | Holcim Neutral | UBS AG | |
| 07.08.15 | Roche buy | Jefferies & Company Inc. | |
| 06.08.15 | Zurich Insurance Sell | S&P Capital IQ | |
| 06.08.15 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.08.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 05.08.15 | UBS buy | Citigroup Corp. | |
| 04.08.15 | Swiss Re Underperform | BNP PARIBAS | |
| 04.08.15 | Holcim Neutral | Goldman Sachs Group Inc. | |
| 03.08.15 | Holcim Neutral | BNP PARIBAS | |
| 03.08.15 | Holcim buy | Kepler Cheuvreux | |
| 31.07.15 | Holcim Neutral | BNP PARIBAS | |
| 31.07.15 | Swiss Re neutral | Barclays Capital | |
| 30.07.15 | Swiss Re buy | S&P Capital IQ | |
| 30.07.15 | Holcim buy | Deutsche Bank AG | |
| 29.07.15 | Holcim kaufen | S&P Capital IQ | |
| 29.07.15 | UBS Underperform | BNP PARIBAS | |
| 29.07.15 | Zurich Insurance Neutral | UBS AG | |
| 29.07.15 | Roche buy | UBS AG | |
| 29.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 28.07.15 | Holcim Reduce | HSBC | |
| 28.07.15 | UBS overweight | JP Morgan Chase & Co. | |
| 28.07.15 | Holcim Neutral | UBS AG | |
| 28.07.15 | Roche overweight | Barclays Capital | |
| 27.07.15 | UBS Strong Buy | S&P Capital IQ | |
| 27.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.07.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 27.07.15 | ABB (Asea Brown Boveri) Neutral | Nomura |